- Treatment & Clinical Trials
- In the News
- Current Research
- Archive: News ∙ Clinical Trials
Treatment & Clinical Trials
- Phase 3 Prevention Trial showed 81% reduced risk of symptomatic SARS-COV-2 infections with subcutaneous administration of REGEN-COV™ (CASIRIVIMAB WITH IMDEVIMAB). University of Minnesota Medical School, Site Investigators: Dr. Anne-Marie Leuck, Dr. Mahsa Abassi, Dr. Matthew Pullen | View Press Release
- Dr. Susan Kline, Principal Investigator, is Enrolling volunteers for Phase 3 Study of NVX-CoV2373 Vaccine. Learn More
- Has someone in your household recently been diagnosed with COVID-19? Volunteer for a Clinical Trial. University of Minnesota is enrolling volunteers in a research study for individuals living with someone who recently tested positive for COVID-19. Learn More
- Dr. David Boulware's hydroxychloroquine trial on early outpatient treatment of COVID-19 has been published in the Annals of Internal Medicine. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
- Dr. David Boulware discusses his Hydroxychloroquine trial on Open Forum Infectious Diseases podcast. How to Conduct a Clinical Trial During a Pandemic
In the News
- Dr. Tim Schacker spoke with Medscape about a study – that he was not involved in – that found a reduction in HIV viral load when monkeys received immunotherapy. He explained that the study needs to be replicated in humans and that it’s likely this approach will need to be combined with others to really control HIV. "Monkeys May Lead the Way for Immunotherapy HIV Cure"
- Dr. David Boulware is mentioned in MedPage Today's article "Large ivermectin study retracted"
- Dr. David Boulware is mentioned by Epoch times: "People who recover from COVID-19 at ‘very low risk’ of re-infection: Study"
- Dr. David Boulware was quoted in MedPage Today: "Awaited Ivermectin Review Is Out — Findings are positive, but critics still want a randomized controlled trial"
- Factcheck.org mentions Dr. David Boulware's Hydroxychloroquine trial: "No New Revelation on Hydroxychloroquine and COVID-19"
- Dr. William Stauffer's study is featured in article Two U of M Medical School studies provide new evidence to battle drug price increases
- Dr. Susan Kline is mentioned in Star Tribune's article Minnesota passes 3 million vaccine recipients mark
- Dr. Susan Kline was honored as part of the Minneapolis/St. Paul Business Journal’s 2021 Health Care Heroes awards
- Dr. Tyler Bold’s Lab is conducting research on antibody prevention of reinfection in his study SERUM SARS-COV-2 NEUTRALIZATION ACTIVITY. Learn More
- A study led by Infectious Diseases Dr. Geoffrey Hart and Dr. Marco Pravetoni (Pharmacology): Understanding Protective Antibody Mechanisms in COVID-19 to Engineer Universal Coronavirus Vaccine. Learn More
- Dr. Timothy Schacker and Dr. Bradley Benson presented COVID-19: The University of Minnesota Response at the DOM Grand Rounds on April 09, 2020
- Study: COVID-19 Rapid Response Grant was received by Dr. Jose Debes and co-investigator Dr. Thomas Leventhal, for their study: Immune Signature to Evaluate COVID-19 Related Liver Injury and Outcomes
- COVID-19 Research at UMN, presented by Dr. Sarah Lofgren, at the Infection & Immunity Research Conference - March 26, 2020
Archive: News ∙ Clinical Trials
About our Division
- Talented Faculty
- Opportunities for Fellows
- Think & Act Globally
The Division of Infectious Diseases and International Medicine (IDIM) has more than 50 faculty overseeing programs in clinical care, education, and research at five teaching hospitals affiliated with the University of Minnesota Medical School: University of Minnesota Medical Center (UMMC), Minneapolis VA Health Care System, Hennepin County Medical Center, Regions Hospital, and Abbott Northwestern Hospital.
Each of these institutions serves somewhat different patient populations, and the clinical and research programs at these sites together with opportunities in global health, provide a remarkable breadth of expertise and academic experiences for trainees in the IDIM Division.
Research & Collaboration
In addition to our clinical scholars and physician scientists with clinical responsibilities, five full-time research faculty contribute importantly to the research mission of our division. The Center for Infectious Diseases and Microbiology Translational Research, an interdisciplinary research center, is the base of operation for these faculty members. Epidemiological research is carried out with colleagues in the School of Public Health, which helps administrate the division’s NIH-funded MPH/MSc-related training program. The Division also benefits from collaborations with faculty members who hold joint academic appointments in other departments, colleagues in the Center for Infectious Diseases Research and Policy, the College of Veterinary Medicine, the Minnesota Department of Health, and a number of community-based Infectious Diseases faculty.
Opportunities for Fellows
Opportunities for Fellows
During their research training, Infectious Diseases Fellows can enter an NIH-supported epidemiology (MPH)/clinical research (MSc) pathway coordinated by the School of Public Health, or they can select a laboratory-based research project at several training sites, including the Center for Translational Research in Microbiology and Infectious Diseases.
Think & Act Globally
Think & Act Globally
Because of a large influx of immigrants to Minnesota and increasing challenges from emerging infections here and abroad, especially in developing countries, our goal is to: "Think and act locally and globally."
About this Conference
The ID Intercity Clinical Case Conference is a regularly scheduled didactic session, sponsored by the Infectious Diseases Division in the Department of Medicine. Presenters are invited from the University of Minnesota, the Minnesota Department of Health and the ID community.
Held weekly on Tuesday mornings throughout the year (with the exception of July), case presentations are interactive and frequently presented as “unknowns,” encouraging discovery and participation with the audience in diagnosis and treatment remedies. Fellows, residents, students, faculty and members of the ID community all present and participate. This series is open to the public and sessions are streamed live and often recorded.
Dr. Jo-Anne Young is the conference director and Betsy Wehrwein is the organizer. For further information, please contact email@example.com.